Showing results (61-70 of 85) with videos related to
Sort By:
Pageof 9
Urology|January 1, 1997
Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogensJ F Caubet, T D Tosteson, E W Dong, et al.The British Journal of Dermatology|August 18, 2012
Recent skin self-examination and doctor visits in relation to melanoma risk and tumour depthL J Titus, K Clough-Gorr, T A Mackenzie, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1993
Phase I/II study of murine monoclonal antibody-ricin A chain (XOMAZYME-Mel) immunoconjugate plus cyclosporine A in patients with metastatic melanomaK Selvaggi, E A Saria, R Schwartz, et al.Investigational New Drugs|January 1, 1995
A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinomaR S Witte, T Leong, M S Ernstoff, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1987
Comparison of gallium-67 versus indium-111 monoclonal antibody (96.5, ZME-018) in detection of human melanoma in athymic miceS M Chan, P B Hoffer, N Maric, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2020
Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategyJ Haanen, M S Ernstoff, Y Wang, et al.The American Journal of Pathology|February 13, 2001
Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoterW W Noll, D R Belloni, J L Rutter, et al.Cancer Research|February 1, 1985
A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trialJ M Kirkwood, J E Harris, R Vera, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinomaM S Ernstoff, S Nair, R R Bahnson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
In vivo biological response to recombinant interferon-gamma during a phase I dose-response trial in patients with metastatic melanomaJ M Kirkwood, M S Ernstoff, T Trautman, et al.Pageof 9